Does B4102 require prior authorization?

No, B4102 does not require prior authorization (high confidence). Covered without prior authorization.

`B4102`, Enteral formula, for adults, used to replace fluids and electrolytes (e.g.,

HCPCS/CPT

No Prior Auth Required

Covered without prior authorization (high confidence)

A Standard Written Order (SWO) must be communicated to the supplier before claim submission; for DMEPOS base items requiring WOPD, the supplier must have a signed SWO/WOPD prior to delivery.
Medical record documentation must justify medical necessity for special formulas, pump use, and any other special enteral items; lack of justification will result in denial.
Documentation of beneficiary diagnosis of exocrine pancreatic insufficiency is required to support coverage of in-line digestive enzyme cartridges (HCPCS B4105).
For refill dispensing of recurring DMEPOS items and supplies, suppliers must contact the beneficiary and document an affirmative response prior to dispensing a refill; contact must occur no sooner than 30 calendar days before expected end of current supply and delivery no sooner than 10 calendar days prior to expected end.

Enteral nutrition is covered when a beneficiary requires feedings via an enteral access device to provide sufficient nutrients to maintain weight and strength commensurate with overall health and has a permanent full or partial non-function of structures that normally permit food to reach the small bowel or a disease that impairs digestion and/or absorption by the small bowel.
Adequate nutrition must not be possible by dietary adjustment and/or oral supplements for the beneficiary to qualify for enteral nutrition coverage.
Enteral formulas consisting of semi-synthetic intact protein/protein isolates (HCPCS B4150 or B4152) are appropriate and covered for the majority of beneficiaries requiring enteral nutrition.
Beneficiaries with non-function of oral/pharyngeal structures due to conditions such as head and neck cancer with reconstructive surgery or central nervous system disease causing severe neuromuscular ingestion impairment may meet coverage criteria.
Beneficiaries with impaired small bowel digestion/absorption from conditions such as inflammatory bowel disease, surgical small bowel resection, cystic fibrosis, chronic pancreatitis, or advanced liver disease may meet coverage criteria.
Treatment: Pharmacotherapy for the treatment of bulimia (e.g., selective serotonin reuptake inhibitors such as fluoxetine, tricyclic anti-depressants, trazodone, topiramate).

ANTHEM-CG-MED-08, Home Enteral Nutrition

L38955, Enteral Nutrition

UHC-POL-enteral-nutrition, Enteral Nutrition (Oral and Tube Feeding)

AETNA-CPB-0511, Eating Disorders

BCBSIL-MED201.011, Nutritional Support

Ask Backwork about documentation requirements, denial risks, or coverage in your state.